Oric Pharmaceuticals, Inc. (ORIC)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch ORIC
See up to 3 months of ORIC. The 7-day demo opens the 1M and 3M ranges and puts ORIC on your watchlist.
Start 7-day demoLatest ORIC insider trades
Richard A. Heyman - DirectorOpen-market sale$45K- Richard A. Heyman - Director
About Oric Pharmaceuticals, Inc. (ORIC)
Oric Pharmaceuticals, Inc. is an SEC registrant, filing under CIK 0001796280, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
ORIC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 8 | 110,800 | $1.49M |
| Option exercise | 12 | 196,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ORIC insider transactions (Form 4)
5618 Form 4 filings on record, the earliest from Dec 17, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Richard A. Heyman - Director | Option exercise | Common Stock | 3,500 | $1.60 | $6K | |
| Richard A. Heyman - Director | Open-market sale | Common Stock | 3,500 | $12.91 footnote F2 | $45K | |
| Richard A. Heyman - Director | Open-market sale | Common Stock | 3,200 | $12.91 footnote F2 | $41K | |
| Richard A. Heyman - Director | Option exercise | Stock Option (right to buy) | 3,500 | $0.00 | - | |
| ||||||
| Dominic Piscitelli - Officer | Option exercise | Common Stock | 13,400 | $4.36 | $58K | |
| Dominic Piscitelli - Officer | Open-market sale | Common Stock | 13,400 | $13.53 footnote F2 | $181K | |
| Dominic Piscitelli - Officer | Option exercise | Stock Option (right to buy) | 13,400 | $0.00 | - | |
| ||||||
| Dominic Piscitelli - Officer | Option exercise | Common Stock | 600 | $4.36 | $3K | |
| Dominic Piscitelli - Officer | Open-market sale | Common Stock | 100 | $13.50 | $1K | |
| Dominic Piscitelli - Officer | Open-market sale | Common Stock | 500 | $13.51 | $7K | |
| Dominic Piscitelli - Officer | Option exercise | Stock Option (right to buy) | 600 | $0.00 | - | |
| Dominic Piscitelli - Officer | Option exercise | Common Stock | 52,000 | $4.36 | $227K | |
| Dominic Piscitelli - Officer | Option exercise | Common Stock | 25,000 | $6.00 | $150K | |
| Dominic Piscitelli - Officer | Open-market sale | Common Stock | 77,000 | $13.69 | $1.05M | |
| Dominic Piscitelli - Officer | Option exercise | Stock Option (right to buy) | 52,000 | $0.00 | - | |
| Dominic Piscitelli - Officer | Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Richard A. Heyman - Director | Option exercise | Common Stock | 3,500 | $1.60 | $6K | |
| Richard A. Heyman - Director | Open-market sale | Common Stock | 7,000 | $12.02 | $84K | |
| Richard A. Heyman - Director | Open-market sale | Common Stock | 6,100 | $12.02 | $73K | |
| Richard A. Heyman - Director | Option exercise | Stock Option (right to buy) | 3,500 | $0.00 | - | |
| Richard A. Heyman | Open-market sale | Common Stock | 300 | $12.00 | $4K | |
| Dominic Piscitelli - Officer | Option exercise | Common Stock | 52,000 | $4.36 | $227K | |
| Dominic Piscitelli - Officer | Option exercise | Stock Option (right to buy) | 52,000 | $0.00 | - | |
| Dominic Piscitelli - Officer | Open-market sale | Common Stock | 52,000 | $13.51 footnote F2 | $703K | |
| ||||||
| Richard A. Heyman | Open-market sale | Common Stock | 3,500 | $12.00 footnote F2 | $42K | |
| Richard A. Heyman | Open-market sale | Common Stock | 3,200 | $12.00 footnote F2 | $38K | |
| ||||||
| Lori Anne Kunkel | Option exercise | Common Stock | 5,534 | $3.75 | $21K | |
| Lori Anne Kunkel | Option exercise | Stock Option (right to buy) | 5,534 | $0.00 | - | |
| Dominic Piscitelli - Officer | Option exercise | Common Stock | 11,000 | $4.36 | $48K | |
| Dominic Piscitelli - Officer | Open-market sale | Common Stock | 11,000 | $14.52 footnote F2 | $160K | |
| Dominic Piscitelli - Officer | Option exercise | Stock Option (right to buy) | 11,000 | $0.00 | - | |
| ||||||
| Jacob Chacko - Officer | Open-market sale | Common Stock | 37,461 | $12.32 footnote F2 | $462K | |
| ||||||
| Richard A. Heyman | Option exercise | Common Stock | 31,353 | $1.60 | $50K | |
| Richard A. Heyman | Option exercise | Common Stock | 1,447 | $3.75 | $5K | |
| Richard A. Heyman | Option exercise | Stock Option (right to buy) | 13,228 | $0.00 | - | |
| Richard A. Heyman | Option exercise | Stock Option (right to buy) | 18,125 | $0.00 | - | |
| Richard A. Heyman | Option exercise | Stock Option (right to buy) | 1,447 | $0.00 | - | |
| Jacob Chacko - Officer | Open-market sale | Common Stock | 34,538 | $12.01 | $415K | |
| Jacob Chacko - Officer | Open-market sale | Common Stock | 53,001 | $12.05 | $639K | |
| Jacob Chacko - Officer | Open-market sale | Common Stock | 125,000 | $10.80 | $1.35M | |
| Dominic Piscitelli - Officer | Open-market sale | Common Stock | 20,000 | $10.05 | $201K | |
| Dominic Piscitelli - Officer | Option exercise | Common Stock | 24,042 | $0.00 | - | |
| Dominic Piscitelli - Officer | Open-market sale | Common Stock | 8,851 | $8.28 | $73K | |
| Dominic Piscitelli - Officer | Option exercise | Restricted Stock Unit | 6,042 | $0.00 | - | |
| Dominic Piscitelli - Officer | Option exercise | Restricted Stock Unit | 8,000 | $0.00 | - | |
| Dominic Piscitelli - Officer | Option exercise | Restricted Stock Unit | 10,000 | $0.00 | - | |
| Jacob Chacko - Officer | Option exercise | Common Stock | 67,000 | $0.00 | - | |
| Jacob Chacko - Officer | Open-market sale | Common Stock | 24,660 | $8.28 | $204K | |
| Jacob Chacko - Officer | Option exercise | Restricted Stock Unit | 16,667 | $0.00 | - | |
| Jacob Chacko - Officer | Option exercise | Restricted Stock Unit | 22,000 | $0.00 | - | |
| Jacob Chacko - Officer | Option exercise | Restricted Stock Unit | 28,333 | $0.00 | - | |
| Pratik S. Multani - Officer | Option exercise | Common Stock | 24,042 | $0.00 | - | |
| Pratik S. Multani - Officer | Open-market sale | Common Stock | 8,850 | $8.28 | $73K | |
| Pratik S. Multani - Officer | Option exercise | Restricted Stock Unit | 6,042 | $0.00 | - | |
| Pratik S. Multani - Officer | Option exercise | Restricted Stock Unit | 8,000 | $0.00 | - | |
| Pratik S. Multani - Officer | Option exercise | Restricted Stock Unit | 10,000 | $0.00 | - | |
Item 2.02, 9.01
Item 5.02, 9.01
Item 5.02, 5.07, 9.01
Item 2.02, 9.01
Recent ORIC Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Richard A, Heyman | Director | 8,100 | $109K | View on EDGAR | |
| Richard A, Heyman | Director | 7,600 |
ORIC insider trading FAQ
What is the latest insider trade for ORIC?
Oric Pharmaceuticals, Inc. (ORIC) had 5 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for ORIC runs to 18 Form 4 filings, the earliest from 2024-12-17. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ORIC stock?
No insider purchases of ORIC were filed in the last 90 days.
How many insiders are selling ORIC stock?
8 insider sales of ORIC were filed in the last 90 days, totaling $1.49M.
Where can I see ORIC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ORIC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Richard A. Heyman view on EDGAR
- - Dominic Piscitelli view on EDGAR
- - Dominic Piscitelli view on EDGAR
- - Dominic Piscitelli view on EDGAR
- - Richard A. Heyman view on EDGAR
- - Richard A. Heyman view on EDGAR
- - Dominic Piscitelli view on EDGAR
- - Richard A. Heyman view on EDGAR
- - Lori Anne Kunkel view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ORIC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ORIC with a 7-day demo
- ORIC on your watchlist
- Every ORIC Form 4 filing on record
- Up to 3 months of ORIC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
